Weighted Gene Co-Expression Network Analysis Identifies Critical Genes in the Development of Heart Failure After Acute Myocardial Infarction
Authors:
Open Access
- 26 November 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 10, 1214
Abstract
Background: The development of heart failure (HF) remains a common complication following an acute myocardial infarction (AMI), and is associated with substantial adverse outcomes. However, the specific predictive biomarkers and candidate therapeutic targets for post-infarction HF have not been fully established. We sought to perform a weighted gene co-expression network analysis (WGCNA) to identify key modules, hub genes, and possible regulatory targets involved in the development of HF following AMI. Methods: Genes exhibiting the most (top 50%) variation in expression levels across samples in a GSE59867 dataset were imported to the WGCNA. Gene Ontology and pathway enrichment analyses were performed on genes identified in the key module by Metascape. Gene regulatory networks were constructed using the microarray probe reannotation and bioinformatics database. Hub genes were screened out from the key module and validated using other datasets. Results: A total of 10,265 most varied genes and six modules were identified between AMI patients who developed HF within 6 months of follow-up and those who did not. Specifically, the blue module was found to be the most significantly related to the development of post-infarction HF. Functional enrichment analysis revealed that the blue module was primarily associated with the inflammatory response, immune system, and apoptosis. Seven transcriptional factors, including SPI1, ZBTB7A, IRF8, PPARG, P65, KLF4, and Fos, were identified as potential regulators of the expression of genes identified in the blue module. Further, non-coding RNAs, including miR-142-3p and LINC00537, were identified as having close interactions with genes from the blue module. A total of six hub genes (BCL3, HCK, PPIF, S100A9, SERPINA1, and TBC1D9B) were identified and validated for their predictive value in identifying future HFs. Conclusions: By using the WGCNA, we provide new insights into the underlying molecular mechanism and molecular markers correlated with HF development following an AMI, which may serve to improve risk stratification, therapeutic decisions, and prognosis prediction in AMI patients.Keywords
This publication has 78 references indexed in Scilit:
- Differential Gene Expression of Cardiac Ion Channels in Human Dilated CardiomyopathyPLOS ONE, 2013
- Landscape of transcription in human cellsNature, 2012
- The PGC-1 cascade as a therapeutic target for heart failureJournal of Molecular and Cellular Cardiology, 2011
- S100A9 Differentially Modifies Phenotypic States of Neutrophils, Macrophages, and Dendritic CellsCirculation, 2011
- Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesisJournal of Clinical Investigation, 2011
- Krüppel-like factor 4 regulates pressure-induced cardiac hypertrophyJournal of Molecular and Cellular Cardiology, 2010
- Bcl3 Interacts Cooperatively with Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Coactivator 1α To Coactivate Nuclear Receptors Estrogen-Related Receptor α and PPARαMolecular and Cellular Biology, 2009
- Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery StenosisCirculation: Cardiovascular Genetics, 2008
- Comparison of non-parametric confidence intervals for the area under the ROC curve of a continuous-scale diagnostic testStatistical Methods in Medical Research, 2007
- Module networks: identifying regulatory modules and their condition-specific regulators from gene expression dataNature Genetics, 2003